Kirin Report issue

For profit
Founded: Tokyo Japan (1885)
Status: Acquired by Kyowa Hakko Kirin (2008)

Organization Overview

First Clinical Trial
2005
NCT00563446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kirin Pharmaceutical (Asia) CO., LTD

Active Ingredients

Drugs in Other Trials (1)

darbepoetin alfa (aranesp) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1